Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
Ubiquitination is cells’ second most abundant posttranslational protein modification after phosphorylation. The ubiquitin–proteasome system (UPS) is critical in maintaining essential life processes such as cell cycle control, DNA damage repair, and apoptosis. Mutations in ubiquitination pathway gene...
Saved in:
| Main Authors: | Aiman B. Awan, Maryiam Jama Ali Osman, Omar M. Khan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/2/69 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
by: Dongha Kim, et al.
Published: (2025-08-01) -
Dysregulation of ubiquitination modification in renal cell carcinoma
by: Hongjie You, et al.
Published: (2024-12-01) -
Unraveling chain specific ubiquitination in cells using tandem ubiquitin binding entities
by: Muhammad Shahzad Ali, et al.
Published: (2025-07-01) -
A No-Brainer! The Therapeutic Potential of TRIM Proteins in Viral and Central Nervous System Diseases
by: Adam Hage, et al.
Published: (2025-04-01) -
Ubiquitination regulates autophagy in cancer: simple modifications, promising targets
by: Yihui Wu, et al.
Published: (2024-10-01)